[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
August 8, 2007

Aspirin Dose and Cardiovascular Disease Prevention

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;298(6):625-626. doi:10.1001/jama.298.6.625-a

To the Editor: Dr Campbell and colleagues1 conducted a systematic review of aspirin dose in prevention of cardiovascular disease. I believe that their use of the differences in bleeding rate observed in the post hoc analysis of the aspirin only group of the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial2 warrants clarification.

First Page Preview View Large
First page PDF preview
First page PDF preview
×